ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
批准号:
3173362
负责人:
BENJAMIN BONAVIDA
金额:
$13.64万
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-07-01 至 1989-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Previous studies of the natural killer (NK) lytic mechanism have provided
evidence for the stimulus secretion model and led to the postulation that
lytic mediators are transferred from the effector to the target cell.
Subsequent work in our laboratory has demonstrated that soluble natural
killer cytotoxic factors (NKCF) can be detected in the supernatant of
effector cells stimulated with NK targets. These factors are NK specific
and lyse only NK sensitive targets. Further studies have shown that NKCF
conform with known characteristics of the NK CMC reaction and we have
postulated that NKCF plays a role in NK CMC cytotoxicity function. The
following model for NK CMC was then proposed by which, following effector
target cell binding, the target stimulates the effector to release NKCF.
These factors then bind to and lyse the target cells. Preliminary studies
have shown that NKCF are glycoproteins and can be fractionated on HPLC
gel-filtration into cytotoxic fractions of molecular weight 20-30
kilodaltons. Furthermore, we have been able to generate xeno and
monoclonal antibodies that can inhibit NK CMC sctivity and in a few
instances neutralize NKCF activity. In the proposal we plan to: 1)
further characterize and biochemically purify NKCF to homogeneity, 2)
characterize antibodies (poly or monoclonal) specific for NKCF, and examine
their role in NK CMC reactions, and 3) in collaboration with other
investigators, compare NKCF with recently described cytolytic granules or
cytotoxins and lymphotoxins derived from NK and CTL lines. We will use
conventional methods of protein purification and structure analysis.
Conventional and monoclonal antibodies will be generated against NKCF and
will be characterized for their role in blocking NK CMC reactions. The
studies proposed are significant and unique in the field of CMC. They are
also clinically important since they describe naturally derived antitumor
cytolytic molecules that may be relevant in immunotherapy. (LB)
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
1987
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Wright,SC, Bonavida,B]
通讯作者:
Bonavida,B
Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
膜结构改变对 NK 细胞介导的细胞毒性的影响。
DOI:
--
发表时间:
1986
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Roozemond,RC, vanderGeer,P, Bonavida,B]
通讯作者:
Bonavida,B
Liposomes can function as targets for natural killer cytotoxic factor but not for tumor necrosis factor.
脂质体可以作为自然杀伤细胞毒性因子的靶标,但不能作为肿瘤坏死因子的靶标。
DOI:
--
发表时间:
1989
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Roozemond,RC, Urli,DC, Jansen,J, Bonavida,B]
通讯作者:
Bonavida,B
Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
通过含有自然杀伤细胞毒性因子 (NKCF) 的脂质体裂解自然杀伤敏感和耐药的肿瘤细胞。
DOI:
10.1016/s0171-2985(87)80098-0
发表时间:
1987
期刊:
Immunobiology
影响因子:
2.8
作者:
[Roozemond,RC, Urli,DC, Wright,SC, Graves,SS, Bonavida,B]
通讯作者:
Bonavida,B
Both NK sensitive and resistant mycoplasma free cell lines stimulate release of NKCF.
NK 敏感和耐药的无支原体细胞系都会刺激 NKCF 的释放。
DOI:
10.1007/978-1-4684-8326-0_13
发表时间:
1985
期刊:
Advances in experimental medicine and biology
影响因子:
--
作者:
[Wright,SC, Bonavida,B]
通讯作者:
Bonavida,B
共 17 条
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
-
批准号:3185063
-
项目类别:
-
资助金额:$14.27万
-
财政年份:1987
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
-
批准号:3185064
-
项目类别:
-
资助金额:$14.37万
-
财政年份:1987
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
-
批准号:3185065
-
项目类别:
-
资助金额:$14.57万
-
财政年份:1987
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
PROGRAMMING FOR LYSIS STAGE IN NK CYTOTOXICITY
-
批准号:3185061
-
项目类别:
-
资助金额:$21.65万
-
财政年份:1987
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
-
批准号:3173361
-
项目类别:
-
资助金额:$13.54万
-
财政年份:1983
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
-
批准号:3173359
-
项目类别:
-
资助金额:$11.92万
-
财政年份:1983
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
ROLE OF NK CYTOTOXIC FACTOR NKCF IN NK CYTOTOXICITY
-
批准号:3173360
-
项目类别:
-
资助金额:$12.56万
-
财政年份:1983
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
INAPPROPRIATE H-2 (K/D) AND IE/C ANTIGENS ON TUMORS
-
批准号:3169721
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1982
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:6533099
-
项目类别:
-
资助金额:$37.51万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:2084873
-
项目类别:
-
资助金额:$29.64万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:6375492
-
项目类别:
-
资助金额:$32.01万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:2084876
-
项目类别:
-
资助金额:$26.15万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:2084874
-
项目类别:
-
资助金额:$21.53万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:2442892
-
项目类别:
-
资助金额:$22.54万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY
-
批准号:3532504
-
项目类别:
-
资助金额:$30.7万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:6166312
-
项目类别:
-
资助金额:$30.63万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:6660247
-
项目类别:
-
资助金额:$41.56万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:2084872
-
项目类别:
-
资助金额:$27.49万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY
-
批准号:3532503
-
项目类别:
-
资助金额:$34.43万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
TUMOR IMMUNOLOGY INSTITUTIONAL TRAINING GRANT
-
批准号:6787631
-
项目类别:
-
资助金额:$35.55万
-
财政年份:1980
-
负责人:BENJAMIN BONAVIDA
-
依托单位:
海外基金